2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Metabolism and Cancer: Novel Therapeutic Targets
Targeting cancer metabolism has emerged as a promising therapeutic approach, particularly in the context of novel drug discovery. Metabolic alterations in cancer cells support their growth, survival, and resistance to treatment. Researchers are investigating how metabolic pathways, such as those involved in glucose uptake, fatty acid oxidation, and amino acid metabolism, can be modulated to disrupt cancer cell function. Targeting metabolic enzymes or signaling pathways could sensitize tumors to chemotherapy, immunotherapy, or radiation, potentially overcoming resistance mechanisms. By identifying specific metabolic vulnerabilities in cancer cells, researchers hope to design more effective and less toxic therapies that selectively target the altered metabolism of cancer cells, offering hope for patients with hard-to-treat cancers.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China